Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study

NeuroImage

Volumn 47, Issue 4, 2009, Pages 1352-1362

  Di Perri, Carol ^a,b   Dwyer, Michael G ^a   Wack, David S ^a   Cox, Jennifer L ^a   Hashmi, Komal ^a   Saluste, Erik ^c   Hussein, Sara ^a   Schirda, Claudiu ^a   Stosic, Milena ^a   Durfee, Jacqueline ^a   Poloni, Guy U ^b   Nayyar, Navdeep ^a   Bergamaschi, Roberto ^b   Zivadinov, Robert ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

Field strength; Multiple sclerosis; Signal abnormalities; Voxel wise comparison

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN REGION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL LOBE; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; SIGNAL PROCESSING;

ADOLESCENT; ADULT; AGED; ALGORITHMS; BRAIN; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 67651175871     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.04.019     Document Type: Article

References (51)

1. Ashburner J., and Friston K.J. Why voxel-based morphometry should be used. Neuroimage 14 (2001) 1238-1243
2. Bachmann R., Reilmann R., Schwindt W., Kugel H., Heindel W., and Kramer S. FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla. Eur. Radiol. 16 (2006) 915-921
3. Barkhof F., Filippi M., van Waesberghe J.H., Molyneux P., Rovaris M., Lycklama a Nijeholt G., et al. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology 49 (1997) 1682-1688
4. Charil A., Zijdenbos A.P., Taylor J., Boelman C., Worsley K.J., Evans A.C., et al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 19 (2003) 532-544
5. DeCarli C., Fletcher E., Ramey V., Harvey D., and Jagust W.J. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 36 (2005) 50-55
6. Di Perri C., Battaglini M., Stromillo M.L., Bartolozzi M.L., Guidi L., Federico A., et al. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Arch. Neurol. 65 (2008) 236-243
7. Dolezal O., Dwyer M.G., Horakova D., Havrdova E., Minagar A., Balachandran S., et al. Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis. Int. Rev. Neurobiol. 79 (2007) 475-489
8. Enzinger C., Smith S., Fazekas F., Drevin G., Ropele S., Nichols T., et al. Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J. Neurol. 253 (2006) 1064-1070
9. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43 (1993) 1683-1689
10. Filippi M., Yousry T., Baratti C., Horsfield M.A., Mammi S., Becker C., et al. Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain 119 Pt 4 (1996) 1349-1355
11. Filippi M., Marciano N., Capra R., Rocca M.A., Prandini F., Gasparotti R., et al. The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis. Neurology 49 (1997) 274-276
12. Filippi M., Rocca M.A., Gasperini C., Sormani M.P., Bastianello S., Horsfield M.A., et al. Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences. AJNR Am. J. Neuroradiol. 20 (1999) 133-137
13. Filippi M., Gawne-Cain M.L., Gasperini C., vanWaesberghe J.H., Grimaud J., Barkhof F., et al. Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis. Neurology 50 (1998) 238-244
14. Filippi M., Rovaris M., Sormani M.P., Horsfield M.A., Rocca M.A., Capra R., et al. Intraobserver and interobserver variability in measuring changes in lesion volume on serial brain MR images in multiple sclerosis. AJNR Am. J. Neuroradiol. 19 (1998) 685-687
15. Fischbach F., and Bruhn H. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review. Liver Int. 28 (2008) 297-307
16. Ghassemi R., Antel S.B., Narayanan S., Francis S.J., Bar-Or A., Sadovnick A.D., et al. Lesion distribution in children with clinically isolated syndromes. Ann. Neurol. 63 (2008) 401-405
17. Gunning-Dixon F.M., and Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 14 (2000) 224-232
18. Hopkins R.O., Beck C.J., Burnett D.L., Weaver L.K., Victoroff J., and Bigler E.D. Prevalence of white matter hyperintensities in a young healthy population. J. Neuroimaging 16 (2006) 243-251
19. Keiper M.D., Grossman R.I., Hirsch J.A., Bolinger L., Ott I.L., Mannon L.J., et al. MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. AJNR Am. J. Neuroradiol. 19 (1998) 1489-1493
20. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
21. Lee D.H., Vellet A.D., Eliasziw M., Vidito L., Ebers G.C., Rice G.P., et al. MR imaging field strength: prospective evaluation of the diagnostic accuracy of MR for diagnosis of multiple sclerosis at 0.5 and 1.5 T. Radiology 194 (1995) 257-262
22. Lee M.A., Smith S., Palace J., and Matthews P.M. Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging. Brain 121 Pt 11 (1998) 2095-2102
23. Longstreth Jr. W.T., Manolio T.A., Arnold A., Burke G.L., Bryan N., Jungreis C.A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27 (1996) 1274-1282
24. Lublin F.D., and Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46 (1996) 907-911
25. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
26. Miller D.H. Magnetic resonance imaging and spectroscopy in multiple sclerosis. Curr. Opin. Neurol. 8 (1995) 210-215
27. Molyneux P.D., Tubridy N., Parker G.J., Barker G.J., MacManus D.G., Tofts P.S., et al. The effect of section thickness on MR lesion detection and quantification in multiple sclerosis. AJNR Am. J. Neuroradiol. 19 (1998) 1715-1720
28. Narayanan S., Fu L., Pioro E., De Stefano N., Collins D.L., Francis G.S., et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann. Neurol. 41 (1997) 385-391
29. Nichols T.E., and Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 15 (2002) 1-25
30. Nielsen K., Rostrup E., Frederiksen J.L., Knudsen S., Mathiesen H.K., Hanson L.G., et al. Magnetic resonance imaging at 3.0 Tesla detects more lesions in acute optic neuritis than at 1.5 Tesla. Invest. Radiol. 41 (2006) 76-82
31. Patola W.B., Coulter B.A., Chipperfield P.M., and Lingawi S.S. A comparison of conventional spin-echo and fast spin-echo in the detection of multiple sclerosis. J. Magn. Reson. Imaging 13 (2001) 657-667
32. Paty D.W., Li D.K., Oger J.J., Kastrukoff L., Koopmans R., Tanton E., et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann. Neurol. 36 Suppl (1994) S95-S96
33. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 58 (2005) 840-846
34. Sakakibara R., Hattori T., Uchiyama T., and Yamanishi T. Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function. J. Neurol. Neurosurg. Psychiatry 67 (1999) 658-660
35. Schima W., Wimberger D., Schneider B., Stiglbauer R., Asenbaum S., and Imhof H. The importance of magnetic field strength in the MR diagnosis of multiple sclerosis: a comparison of 0.5 and 1.5 T. Rofo 158 (1993) 368-371
36. Sicotte N.L., Voskuhl R.R., Bouvier S., Klutch R., Cohen M.S., and Mazziotta J.C. Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest. Radiol. 38 (2003) 423-427
37. Smith S.M., and Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44 (2009) 83-98
38. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 Suppl. 1 (2004) S208-S219
39. Starr J.M., Leaper S.A., Murray A.D., Lemmon H.A., Staff R.T., Deary I.J., et al. Brain white matter lesions detected by magnetic resonance [correction of resosnance] imaging are associated with balance and gait speed. J. Neurol. Neurosurg. Psychiatry 74 (2003) 94-98
40. Steffens D.C., Bosworth H.B., Provenzale J.M., and MacFall J.R. Subcortical white matter lesions and functional impairment in geriatric depression. Depress. Anxiety 15 (2002) 23-28
41. Takao M., Koto A., Tanahashi N., Fukuuchi Y., Takagi M., and Morinaga S. Pathologic findings of silent hyperintense white matter lesions on MRI. J. Neurol. Sci. 167 (1999) 127-131
42. Wattjes M.P., Harzheim M., Kuhl C.K., Gieseke J., Schmidt S., Klotz L., et al. Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic MR imaging criteria for multiple sclerosis?. AJNR Am. J. Neuroradiol. 27 (2006) 1794-1798
43. Wattjes M.P., Lutterbey G.G., Harzheim M., Gieseke J., Traber F., Klotz L., et al. Imaging of inflammatory lesions at 3.0 Tesla in patients with clinically isolated syndromes suggestive of multiple sclerosis: a comparison of fluid-attenuated inversion recovery with T2 turbo spin-echo. Eur. Radiol. 16 (2006) 1494-1500
44. Wattjes M.P., Harzheim M., Lutterbey G.G., Hojati F., Simon B., Schmidt S., et al. Does high field MRI allow an earlier diagnosis of multiple sclerosis?. J. Neurol. 255 (2008) 1159-1163
45. Wen W., and Sachdev P. The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage 22 (2004) 144-154
46. Wen W., Sachdev P.S., Li J.J., Chen X., and Anstey K.J. White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44-48. Hum. Brain Mapp. 30 (2009) 1155-1167
47. Yousry T.A., Filippi M., Becker C., Horsfield M.A., and Voltz R. Comparison of MR pulse sequences in the detection of multiple sclerosis lesions. AJNR Am. J. Neuroradiol. 18 (1997) 959-963
48. Zhang Y., Zabad R.K., Wei X., Metz L.M., Hill M.D., and Mitchell J.R. Deep grey matter "black T2" on 3 Tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult. Scler. 13 (2007) 880-883
49. Zivadinov R. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?. Neurology 68 (2007) S72-82 discussion S91-6
50. Zivadinov R., Rudick R.A., De Masi R., Nasuelli D., Ukmar M., Pozzi-Mucelli R.S., et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 57 (2001) 1239-1247
51. Zivadinov R., Bagnato F., Nasuelli D., Bastianello S., Bratina A., Locatelli L., et al. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis. J. Neurol. Sci. 223 (2004) 185-193